BioMarin Announces Record Revenues in First Quarter 2022

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/14/2026

1. WDAY
2. JNJ
3. AAPL
4. META
5. NVDA
6. AMAT
7. NRIX
8. SPY
9. OIG
10. BAC

Go back to BioMarin Announces Record Revenues in First Quarter 2022

BioMarin Pharma (BMRN) Tops Q1 EPS by 46c

April 27, 2022 4:16 PM EDT

BioMarin Pharma (NASDAQ: BMRN) reported Q1 EPS of $0.63, $0.46 better than the analyst estimate of $0.17. Revenue for the quarter came in at $519 million versus the consensus estimate of $507.52 million.

GUIDANCE:

BioMarin Pharma sees FY2022 revenue of $2.05-2.15 billion.

For earnings history and earnings-related data on BioMarin Pharma (BMRN) click here.

... More